Dr. Masoud Mozafari is a Fellow at Lunenfeld Tanenbaum Research Institute, Mount Sinai Health Hospital, University of Toronto. He was previously Assistant Professor and Director of the Bioengineering Lab, at the Nanotechnology and Advanced Materials Department, Materials and Energy Research Center, Cellular and Molecular Research Center, and Department of Tissue Engineering and Regenerative Medicine of the Iran University of Medical Sciences (IUMS), Tehran, Iran. Dr. Mozafari’s research interests range across biomaterials, nanotechnology, and tissue engineering, and he is known for the development of strategies for the treatment of damaged tissues and organs, and controlling biological substances for targeted delivery into the human body. Dr. Mozafari has received several awards, including the Khwarizmi Award and the Julia Polak European Doctorate Award for outstanding translational research contributions to the field of biomaterials. He has also received the WIPO Medal for Inventors from The World Intellectual Property Organization (WIPO), in recognition of his contributions to economic and technological development. Dr. Mozafari is currently working on the editorial board of several journals.

• Part I: Principles of nanotechnology-based drug delivery1. Principles of nanosized delivery systems2. Controlled/localized release and nanotechnology 3. Stimuli-sensitive delivery systems4. Sustainable delivery systems through green nanotechnology5. Recent advances in multifunctional nanoengineered biomaterials6. Mathematical and computational modelling of delivery systems7. Nanoengineered biomaterials for delivery purposes: Past, present, and futurePart II: Nanoengineered Biomaterials for drug delivery8. Synthetic and natural polymer-based nanoengineered biomaterials for drug delivery9. Protein and peptide-based delivery systems10. Lipid vesicles: Potentials as delivery systems11. Block copolymers for nanoscale drug and gene delivery12. Dendrimers for delivery purposes 13. Reversible cross-linked polymeric for delivery puposes14. Polymeric micelles as delivery systems15. Metallic nanoparticulate delivery systems 16. Gold nanoparticles in delivery applications17. Silver nanoparticles for delivery purposes  18. Magnetically-based nanocarriers in drug delivery19. Iron oxide nanoparticles for delivery purposes20. Porous silica nanoparticles for delivery applications21. Carbon-family materials for delivery applicationsPart III: Delivery routes of Nanoengineered Biomaterials 22. Potential nanocarriers for the delivery of drugs to the brain23. Nanotechnology for oral drug delivery and targeting24. Nanotechnology for ocular and otic drug delivery and targeting25. Nanoparticulate systems for dental drug delivery26. Nanotechnology for pulmonary and nasal drug delivery27. Nanotechnology for topical and transdermal drug delivery and targeting28. Nanoemulsions for intravenous drug delivery29. Nanoparticles for mucosal vaccine delivery30. Nanotechnology for vaginal drug delivery and targeting31. Nanotechnology for intracellular delivery and targetingPart IV: Applications of Nanoengineered Biomaterials in Drug Delivery 32. Nanoengineered biomaterials for infectious diseases33. Nanoengineered biomaterials for neurodegenerative disorders34. Nanoengineered biomaterials for inflammatory diseases35. Nanoengineered biomaterials for cancer diagnosis and treatment 36. Nanoengineered biomaterials for diabetes37. Nanoengineered biomaterials for cardiovascular disease38. Nanotechnology-based biosensors in drug delivery

Dr. Masoud Mozafari is a Fellow at Lunenfeld Tanenbaum Research Institute, Mount Sinai Health Hospital, University of Toronto. He was previously Assistant Professor and Director of the Bioengineering Lab, at the Nanotechnology and Advanced Materials Department, Materials and Energy Research Center, Cellular and Molecular Research Center, and Department of Tissue Engineering and Regenerative Medicine of the Iran University of Medical Sciences (IUMS), Tehran, Iran. Dr. Mozafari’s research interests range across biomaterials, nanotechnology, and tissue engineering, and he is known for the development of strategies for the treatment of damaged tissues and organs, and controlling biological substances for targeted delivery into the human body. Dr. Mozafari has received several awards, including the Khwarizmi Award and the Julia Polak European Doctorate Award for outstanding translational research contributions to the field of biomaterials. He has also received the WIPO Medal for Inventors from The World Intellectual Property Organization (WIPO), in recognition of his contributions to economic and technological development. Dr. Mozafari is currently working on the editorial board of several journals.

• Part I: Principles of nanotechnology-based drug delivery1. Principles of nanosized delivery systems2. Controlled/localized release and nanotechnology 3. Stimuli-sensitive delivery systems4. Sustainable delivery systems through green nanotechnology5. Recent advances in multifunctional nanoengineered biomaterials6. Mathematical and computational modelling of delivery systems7. Nanoengineered biomaterials for delivery purposes: Past, present, and futurePart II: Nanoengineered Biomaterials for drug delivery8. Synthetic and natural polymer-based nanoengineered biomaterials for drug delivery9. Protein and peptide-based delivery systems10. Lipid vesicles: Potentials as delivery systems11. Block copolymers for nanoscale drug and gene delivery12. Dendrimers for delivery purposes 13. Reversible cross-linked polymeric for delivery puposes14. Polymeric micelles as delivery systems15. Metallic nanoparticulate delivery systems 16. Gold nanoparticles in delivery applications17. Silver nanoparticles for delivery purposes  18. Magnetically-based nanocarriers in drug delivery19. Iron oxide nanoparticles for delivery purposes20. Porous silica nanoparticles for delivery applications21. Carbon-family materials for delivery applicationsPart III: Delivery routes of Nanoengineered Biomaterials 22. Potential nanocarriers for the delivery of drugs to the brain23. Nanotechnology for oral drug delivery and targeting24. Nanotechnology for ocular and otic drug delivery and targeting25. Nanoparticulate systems for dental drug delivery26. Nanotechnology for pulmonary and nasal drug delivery27. Nanotechnology for topical and transdermal drug delivery and targeting28. Nanoemulsions for intravenous drug delivery29. Nanoparticles for mucosal vaccine delivery30. Nanotechnology for vaginal drug delivery and targeting31. Nanotechnology for intracellular delivery and targetingPart IV: Applications of Nanoengineered Biomaterials in Drug Delivery 32. Nanoengineered biomaterials for infectious diseases33. Nanoengineered biomaterials for neurodegenerative disorders34. Nanoengineered biomaterials for inflammatory diseases35. Nanoengineered biomaterials for cancer diagnosis and treatment 36. Nanoengineered biomaterials for diabetes37. Nanoengineered biomaterials for cardiovascular disease38. Nanotechnology-based biosensors in drug delivery

Dr. Masoud Mozafari is a Fellow at Lunenfeld Tanenbaum Research Institute, Mount Sinai Health Hospital, University of Toronto. He was previously Assistant Professor and Director of the Bioengineering Lab, at the Nanotechnology and Advanced Materials Department, Materials and Energy Research Center, Cellular and Molecular Research Center, and Department of Tissue Engineering and Regenerative Medicine of the Iran University of Medical Sciences (IUMS), Tehran, Iran. Dr. Mozafari’s research interests range across biomaterials, nanotechnology, and tissue engineering, and he is known for the development of strategies for the treatment of damaged tissues and organs, and controlling biological substances for targeted delivery into the human body. Dr. Mozafari has received several awards, including the Khwarizmi Award and the Julia Polak European Doctorate Award for outstanding translational research contributions to the field of biomaterials. He has also received the WIPO Medal for Inventors from The World Intellectual Property Organization (WIPO), in recognition of his contributions to economic and technological development. Dr. Mozafari is currently working on the editorial board of several journals.

• Part I: Principles of nanotechnology-based drug delivery1. Principles of nanosized delivery systems2. Controlled/localized release and nanotechnology 3. Stimuli-sensitive delivery systems4. Sustainable delivery systems through green nanotechnology5. Recent advances in multifunctional nanoengineered biomaterials6. Mathematical and computational modelling of delivery systems7. Nanoengineered biomaterials for delivery purposes: Past, present, and futurePart II: Nanoengineered Biomaterials for drug delivery8. Synthetic and natural polymer-based nanoengineered biomaterials for drug delivery9. Protein and peptide-based delivery systems10. Lipid vesicles: Potentials as delivery systems11. Block copolymers for nanoscale drug and gene delivery12. Dendrimers for delivery purposes 13. Reversible cross-linked polymeric for delivery puposes14. Polymeric micelles as delivery systems15. Metallic nanoparticulate delivery systems 16. Gold nanoparticles in delivery applications17. Silver nanoparticles for delivery purposes  18. Magnetically-based nanocarriers in drug delivery19. Iron oxide nanoparticles for delivery purposes20. Porous silica nanoparticles for delivery applications21. Carbon-family materials for delivery applicationsPart III: Delivery routes of Nanoengineered Biomaterials 22. Potential nanocarriers for the delivery of drugs to the brain23. Nanotechnology for oral drug delivery and targeting24. Nanotechnology for ocular and otic drug delivery and targeting25. Nanoparticulate systems for dental drug delivery26. Nanotechnology for pulmonary and nasal drug delivery27. Nanotechnology for topical and transdermal drug delivery and targeting28. Nanoemulsions for intravenous drug delivery29. Nanoparticles for mucosal vaccine delivery30. Nanotechnology for vaginal drug delivery and targeting31. Nanotechnology for intracellular delivery and targetingPart IV: Applications of Nanoengineered Biomaterials in Drug Delivery 32. Nanoengineered biomaterials for infectious diseases33. Nanoengineered biomaterials for neurodegenerative disorders34. Nanoengineered biomaterials for inflammatory diseases35. Nanoengineered biomaterials for cancer diagnosis and treatment 36. Nanoengineered biomaterials for diabetes37. Nanoengineered biomaterials for cardiovascular disease38. Nanotechnology-based biosensors in drug delivery